SME June 10, 2020
Bruce Morey

One of the highlights of the 3DHEALS 2020 virtual conference on June 6 and 7, 2020 was a keynote from Sam Onukuri, senior fellow at Johnson & Johnson 3D Printing. He explained how Johnson & Johnson is leveraging 3D printing technology to transform design, manufacturing and delivery across its medical device, consumer and pharmaceutical businesses. He also made a few predictions about the future of the technology in medical care.

Emerging Customer Expectations

A number of factors are fueling an “urgency for change”, according to Onukuri. Key are ‘pay for value’, an aging population, market consolidation and risk, and changes in regulatory oversight. “Critical outcomes are going to be a lot more important for reimbursement or even adoption. Personalization and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: 3D Printing, Conferences / Podcast, Technology, Trends
WASP Highlights Advances in Healthcare 3D Printing at Italy’s Exposanità 2024
3D Systems Brings 3D Printed PEEK Cranial Implant to the U.S. with FDA Clearance
3D Printing Market Hits $14.7B Amid Challenges in 2023
World’s First Bioprinted Trachea Transplant Marks a New Era in Medical Innovation
AI-Powered 3D Printing Redefines Implant Surgery

Share This Article